| (Values in U.S. Thousands) | Mar, 2014 | Dec, 2013 | Sep, 2013 | Jun, 2013 | Mar, 2013 |
| Sales | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 |
| Net Income Growth | unch | unch | unch | unch | unch |
Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Nanogen's is a supplier of molecular diagnostic tests to the medical community and to clinical researchers. They commercialize instruments, consumables, electronic microarrays and reagents through a direct sales force and distributors in North America, Europe and Asia. The Company also provide a highly experienced technical support staff and Field Application Specialists dedicated to helping their customers around the world. The NanoChip(r) Molecular Biology Workstation, the Company's first commercial product, is an automated, multi-purpose instrument primarily used for DNA-based analyses. Researchers in the field of molecular biology and genetics use the platform to study how genes function and to understand the correlation between genetic variation and disease. The NanoChip(r) System can also be used for human identification, important in the forensics field. Their products are ASRs/Applications, NanoChip(r) MBW Workstation, NanoChip(r) 400 System, NanoChip(r) Electronic Microarray and Consumables.
Fiscal Year End Date: 12/31